Literature DB >> 23790544

Age and sex patterns of drug prescribing in a defined American population.

Wenjun Zhong1, Hilal Maradit-Kremers, Jennifer L St Sauver, Barbara P Yawn, Jon O Ebbert, Véronique L Roger, Debra J Jacobson, Michaela E McGree, Scott M Brue, Walter A Rocca.   

Abstract

OBJECTIVE: To describe the age and sex patterns of drug prescribing in Olmsted County, Minnesota. PATIENTS AND METHODS: Population-based drug prescription records for the Olmsted County population in 2009 were obtained using the Rochester Epidemiology Project medical records linkage system (n=142,377). Drug prescriptions were classified using RxNorm codes and were grouped using the National Drug File-Reference Terminology.
RESULTS: Overall, 68.1% of the population (n=96,953) received a prescription from at least 1 drug group, 51.6% (n=73,501) received prescriptions from 2 or more groups, and 21.2% (n=30,218) received prescriptions from 5 or more groups. The most commonly prescribed drug groups in the entire population were penicillins and β-lactam antimicrobials (17%; n=23,734), antidepressants (13%; n=18,028), opioid analgesics (12%; n=16,954), antilipemic agents (11%; n=16,082), and vaccines/toxoids (11%; n=15,918). However, prescribing patterns differed by age and sex. Vaccines/toxoids, penicillins and β-lactam antimicrobials, and antiasthmatic drugs were most commonly prescribed in persons younger than 19 years. Antidepressants and opioid analgesics were most commonly prescribed in young and middle-aged adults. Cardiovascular drugs were most commonly prescribed in older adults. Women received more prescriptions than men for several drug groups, in particular for antidepressants. For several drug groups, use increased with advancing age.
CONCLUSION: This study provides valuable baseline information for future studies of drug utilization and drug-related outcomes in this population.
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790544      PMCID: PMC3754826          DOI: 10.1016/j.mayocp.2013.04.021

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  41 in total

1.  Geographic variation in Medicare drug spending.

Authors:  Yuting Zhang; Katherine Baicker; Joseph P Newhouse
Journal:  N Engl J Med       Date:  2010-06-09       Impact factor: 91.245

2.  Use of chronic medications among a large, commercially-insured US population.

Authors:  Catherine M Roe; Ann M McNamara; Brenda R Motheral
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-06       Impact factor: 2.890

3.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca
Journal:  Int J Epidemiol       Date:  2012-11-18       Impact factor: 7.196

4.  A short test of mental status: description and preliminary results.

Authors:  E Kokmen; J M Naessens; K P Offord
Journal:  Mayo Clin Proc       Date:  1987-04       Impact factor: 7.616

5.  Drug use and expenditures in 1982.

Authors:  C Baum; D L Kennedy; M B Forbes; J K Jones
Journal:  JAMA       Date:  1985-01-18       Impact factor: 56.272

6.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

7.  Drug use in the United States in 1981.

Authors:  C Baum; D L Kennedy; M B Forbes; J K Jones
Journal:  JAMA       Date:  1984-03-09       Impact factor: 56.272

8.  Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.

Authors:  Jae Kennedy; Iulia Tuleu; Katherine Mackay
Journal:  J Manag Care Pharm       Date:  2008 Jul-Aug

9.  National patterns in antidepressant medication treatment.

Authors:  Mark Olfson; Steven C Marcus
Journal:  Arch Gen Psychiatry       Date:  2009-08

10.  Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients.

Authors:  L Kotzan; N V Carroll; J A Kotzan
Journal:  Am J Hosp Pharm       Date:  1989-02
View more
  52 in total

1.  U.S. News Media Coverage of Pharmaceutical Pollution in the Aquatic Environment: A Content Analysis of the Problems and Solutions Presented by Actors.

Authors:  Benjamin Blair; Daniel Zimny-Schmitt; Murray A Rudd
Journal:  Environ Manage       Date:  2017-05-10       Impact factor: 3.266

2.  Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.

Authors:  Jay C Erie; Scott M Brue; Alanna M Chamberlain; David O Hodge
Journal:  Am J Ophthalmol       Date:  2014-03-14       Impact factor: 5.258

3.  Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.

Authors:  Alanna M Chamberlain; Sarah S Cohen; Susan A Weston; Kathleen M Fox; Pin Xiang; Jill M Killian; Yi Qian
Journal:  Am J Cardiol       Date:  2019-03-08       Impact factor: 2.778

4.  The influence of non-steroidal anti-inflammatory drugs on the gut microbiome.

Authors:  M A M Rogers; D M Aronoff
Journal:  Clin Microbiol Infect       Date:  2015-10-16       Impact factor: 8.067

Review 5.  Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings.

Authors:  Jennifer L Kuntz; Monika M Safford; Jasvinder A Singh; Shobha Phansalkar; Sarah P Slight; Qoua Liang Her; Nancy Allen Lapointe; Robin Mathews; Emily O'Brien; William B Brinkman; Kevin Hommel; Kevin C Farmer; Elissa Klinger; Nivethietha Maniam; Heather J Sobko; Stacy C Bailey; Insook Cho; Maureen H Rumptz; Meredith L Vandermeer; Mark C Hornbrook
Journal:  Patient Educ Couns       Date:  2014-09-16

Review 6.  Potential Upstream Strategies for the Mitigation of Pharmaceuticals in the Aquatic Environment: a Brief Review.

Authors:  Benjamin D Blair
Journal:  Curr Environ Health Rep       Date:  2016-06

7.  Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy.

Authors:  Kelly C Young-Wolff; Daniella Klebaner; Constance Weisner; Michael Von Korff; Cynthia I Campbell
Journal:  Clin J Pain       Date:  2017-08       Impact factor: 3.442

8.  A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species.

Authors:  Arielle Butts; Parker Reitler; Andrew T Nishimoto; Christian DeJarnette; Leanna R Estredge; Tracy L Peters; Michael P Veve; P David Rogers; Glen E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

9.  Incidence and Risk Factors for Progression From Short-term to Episodic or Long-term Opioid Prescribing: A Population-Based Study.

Authors:  W Michael Hooten; Jennifer L St Sauver; Michaela E McGree; Debra J Jacobson; David O Warner
Journal:  Mayo Clin Proc       Date:  2015-07       Impact factor: 7.616

Review 10.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.